Enhancing Social Cognition training Program's Efficacy
Not Applicable
Recruiting
- Conditions
- schizophrenia spectrum disorder, autism spectrum disorder
- Registration Number
- JPRN-UMIN000052584
- Lead Sponsor
- Kyoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Not provided
Exclusion Criteria
1. Current substance or alcohol abuse 2. Traumatic head injury, cerebrovascular disease, or neurodegenerative disease 3. At high risk of violence, suicide attempts, or impulsive behavior
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What neurobiological mechanisms underlie social cognition training efficacy in EnSCoPE study for schizophrenia and autism spectrum disorders?
How does EnSCoPE social cognition training compare to standard antipsychotics in improving social functioning for schizophrenia spectrum disorder?
Which neuroimaging biomarkers predict response to social cognition training in EnSCoPE study for autism spectrum disorder and schizophrenia spectrum disorder?
What are the potential adverse events and management strategies for social cognition training in EnSCoPE study for schizophrenia and autism spectrum disorders?
What pharmacological adjuncts, such as antipsychotics or SSRIs, enhance social cognition training outcomes in EnSCoPE study for schizophrenia and autism spectrum disorders?